Difference between revisions of "WSI21-60-Case-3"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 52: Line 52:
 
|subject=Z0FBQUFBQmdZUGd4ZFZUOVFMYk9XaWw5aTNsbk02WHk0UXVZR21mdllXQksteWVIdlMzMU1ucTBYMFBDU0MybFRhZUcySUJEbXkwdVprOWFaRkZMdUhXV0F5WUNGakVFWXc9PQ
 
|subject=Z0FBQUFBQmdZUGd4ZFZUOVFMYk9XaWw5aTNsbk02WHk0UXVZR21mdllXQksteWVIdlMzMU1ucTBYMFBDU0MybFRhZUcySUJEbXkwdVprOWFaRkZMdUhXV0F5WUNGakVFWXc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Em99
 +
|authoredOn=March 28, 2021 09:41:31 PM
 
}}
 
}}

Latest revision as of 14:16, December 9, 2024

WSI21-60-Case-3
Lung mass
Poorly differentiated carcinoma, consistent with metastasis from the patient's known transitional cell carcinoma.
April 7, 2021 12:00:00 AM